Marty Makary, 27th Commissioner of the U.S. FDA, shared a post on X:
“Transparency in FDA decisions can create predictable pathways and ultimately deliver on one of our top goals: more cures and meaningful treatments for Americans. Read more in my latest op-ed.”
More posts featuring FDA on OncoDaily.